<code id='27D547D0F3'></code><style id='27D547D0F3'></style>
    • <acronym id='27D547D0F3'></acronym>
      <center id='27D547D0F3'><center id='27D547D0F3'><tfoot id='27D547D0F3'></tfoot></center><abbr id='27D547D0F3'><dir id='27D547D0F3'><tfoot id='27D547D0F3'></tfoot><noframes id='27D547D0F3'>

    • <optgroup id='27D547D0F3'><strike id='27D547D0F3'><sup id='27D547D0F3'></sup></strike><code id='27D547D0F3'></code></optgroup>
        1. <b id='27D547D0F3'><label id='27D547D0F3'><select id='27D547D0F3'><dt id='27D547D0F3'><span id='27D547D0F3'></span></dt></select></label></b><u id='27D547D0F3'></u>
          <i id='27D547D0F3'><strike id='27D547D0F3'><tt id='27D547D0F3'><pre id='27D547D0F3'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:99933
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Change Healthcare can notify patients about the breach, HHS says
          Change Healthcare can notify patients about the breach, HHS says

          KentNishimura/GettyImagesChangeHealthcarecannotifypatientswhosesensitivehealthinformationhasbeenexpo

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          At ASCO, AstraZeneca reports strong data for breast cancer drug

          ThefuturelooksevenbrighterfortheblockbusterEnhertu,showcasedhereatASCO.ADAMFEUERSTEIN/STATCHICAGO—Th